Literature DB >> 11006477

Malaria vaccines.

R F Anders1, A Saul.   

Abstract

Although the possibility of a live attenuated malaria vaccine has been considered, current malaria vaccine development activities are dominated by attempts to develop a subunit vaccine. Hence, it is entirely appropriate that a session of the Molecular Approaches to Malaria conference, Lorne, Australia, 2-5 February 2000, was devoted to vaccine development. The oral presentations in this session and the relevant poster presentations are outlined here by Robin Anders and Allan Saul.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006477     DOI: 10.1016/s0169-4758(00)01784-1

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  7 in total

1.  Independent translocation of two micronemal proteins in developing Plasmodium falciparum merozoites.

Authors:  Julie Healer; Simon Crawford; Stuart Ralph; Geoff McFadden; Alan F Cowman
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

2.  QSAR for anti-malarial activity of 2-aziridinyl and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives.

Authors:  Mohamed Zahouily; Mohamed Lazar; Abdelhakim Elmakssoudi; Jamila Rakik; Sanaa Elaychi; A Rayadh
Journal:  J Mol Model       Date:  2005-12-09       Impact factor: 1.810

Review 3.  Integrated approach to malaria control.

Authors:  Clive Shiff
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

4.  Merozoite surface protein 1 recognition of host glycophorin A mediates malaria parasite invasion of red blood cells.

Authors:  Michael R Baldwin; Xuerong Li; Toshihiko Hanada; Shih-Chun Liu; Athar H Chishti
Journal:  Blood       Date:  2015-03-16       Impact factor: 22.113

5.  Members of the merozoite surface protein 7 family with similar expression patterns differ in ability to protect against Plasmodium yoelii malaria.

Authors:  Kerrianne Mello; Thomas M Daly; Carole A Long; James M Burns; Lawrence W Bergman
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

6.  Plasmodium vivax: paroxysm-associated lipids mediate leukocyte aggregation.

Authors:  Nadira Karunaweera; Deepani Wanasekara; Vishvanath Chandrasekharan; Kamini Mendis; Richard Carter
Journal:  Malar J       Date:  2007-05-22       Impact factor: 2.979

7.  Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults.

Authors:  Jinhong Hu; Zhihui Chen; Jun Gu; Mobin Wan; Qian Shen; Marie-Paule Kieny; Jia He; Zhen Li; Qingfeng Zhang; Zarifah Hussain Reed; Yongmei Zhu; Wenjie Li; Yang Cao; Li Qu; Zhifang Cao; Qiang Wang; Haitao Liu; Xuegong Pan; Xiudong Huang; Dongmei Zhang; Xiangyang Xue; Weiqing Pan
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.